Guest Editorial: Systems Biology, the Second Time Around by DeLisi, Charles
When T.S. Eliot (Eliot 1963) wrote “. . . the end of all our exploring
Will be to arrive where we started And know the place for the first
time,” he was probably not thinking explicitly of science, but as sci-
ence is deeply imbedded in the human condition, we should not be
surprised that these words ring true. 
Systems biology as a quantitative science dates at least to
Hermann von Helmholtz, the 19th century German physicist whose
studies of metabolism led to the first law of thermodynamics.
Helmholtz explored human physiology in its entirety, making fun-
damental contributions to audition, vision, the conduction of the
nervous impulse and, perhaps most important in so far as systems
biology is concerned, physiologic energy balance. Our understanding
of physiologic systems has of course evolved substantially during the
past 150 years, and today sophisticated, if domain-specific, mathe-
matical models are used to simulate, plan, and interpret experiments
in numerous branches of biomedicine including endocrinology, car-
diovascular physiology, immunology, neurophysiology, and the cog-
nitive sciences. Moreover, with the completion of the first phase of
the visible human project, which provides high-resolution MR (mag-
netic resonance) and CT (computed tomography) imaging scans of
male and female anatomies, we can seriously contemplate coupling
organ-level models that integrate anatomical, biophysical, and physi-
ologic data to produce a computer-based virtual human. 
Molecules are not currently the building blocks of useful organ-
level models. Instead, the cell is modeled at low resolution, if not as
a black box. For example, a model of the humoral immune
response might include B-cell trafficking, stimulation by antigen,
and regulation by T cells. The dynamics of helper and suppressor
T cells and their interaction with antigen-presenting cells could be
modeled as a separate subsystem, or module, whose output served
as input to the B-cell module. The response of B cells to antigen
would then be modeled using experimentally determined rate con-
stants for antigen–receptor interaction to obtain receptor occu-
pancy, and a phenomenologic function determined experimentally
would relate occupancy and T-cell state to antibody secretion and
B-cell proliferation rate. 
The levels of depth that would not be modeled explicitly are
apparent. The antigen–receptor rate constants could themselves in
principle be calculated in terms of the detailed atomic-level struc-
tures of the antigen and immunoglobulin receptors, using long-
and short-range force fields determined by quantum chemical cal-
culations and thermodynamic measurements. Such calculations,
even if crystal structures were available and the force fields were
known precisely, would need to take into account conformational
rearrangements in surface side chains, some backbone adaptation,
and solvent restructuring. Such calculations are currently too diffi-
cult to perform routinely with even moderate precision.
Similarly, one could in principle model by any number of meth-
ods—physical chemical, probabilistic, etc.—the signaling pathways
leading from receptor occupancy to gene activation, with all the var-
ious post-translational modifications and their dependence on the
state of the cell, terminating in the modulation of sets of genes com-
binatorially regulated by sets of transcrip-
tion factors. But the information required is
currently far too sketchy for detailed cell-
based models to be useful inputs to organ-
and tissue-level models. The advantages of
including such deeper-level models explicitly would be a) the con-
nection they may provide between the (dynamic) state of the cell’s
surface and the gene–protein–metabolite network topology in the
interior of the cell, thus providing an entrée to a global-integrated
model; b) their ability to integrate cell physiology with cell
anatomy—just as a virtual human would integrate anatomy and
physiology at the organ level; and c) the foundation they would pro-
vide for deep design; that is, for rational molecular manipulations
aimed at production of prespecified phenotypes. 
Although historical and global perspectives remind us that we are
not in an entirely new place, profound changes have occurred in
recent years—changes that are driving a fundamental shift in the cul-
ture and content of the life sciences. One such change is, of course,
genomic decoding—work that has only just begun. The next
5–10 years will see the production of complete lists of parts of
eukaryotic cells, and the next 15–20 years will see reasonably com-
plete wiring diagrams. But—a worn analogy not withstanding—
understanding a cell from its list of parts is far more complex than
understanding a Boeing 747 airplane or many other complex sys-
tems. The cell is not hard wired, therefore a “wiring diagram” only
provides, after much analysis, a combinatorially rich repertoire of cir-
cuit modules, particular subsets of which are selected by particular
environments. And because a cell’s environment is in fugue, the
problem of systems biology is understanding the rules of subset selec-
tion, and connecting recurrent functional modules to phenotype. 
There are many ways to carry out such a program at various
levels of spatial and temporal resolution. The level selected depends
on experimental or clinical goals. But regardless of the approach
used, connecting the genomic revolution and a biology that would
understand the cell as a hierarchical system of environmentally
selected functional modules is a long-term program. Along the
way, as our understanding deepens and as our models attain
broader phenomenologic coverage, we can expect to attain a greatly
accelerated understanding of evolutionary and developmental biol-
ogy and greater precision in identifying drug targets and individu-
alizing therapies. 
While genomics—and I use the word canonically—does not in
itself enable a cell systems biology, it is providing the tools and data
that embolden us to begin thinking and working seriously toward
that goal. But it is doing much more. It has married the two most
powerful technologies of the 20th century—computer science and
molecular biology. Computer science is the sine qua non for postge-
nomic biology, and the dexterity with which its leaders have
responded to the biological challenge is one of the great stories in
the sociology of science. Nevertheless, the fundamental cultural
challenge remains with the biology community itself . The pace of
progress will continue to be rate limited by the ability of our uni-
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